Alliance between Fondazione Telethon and biopharmaceutical company Shire for research and development of new therapies for rare genetic diseases
Fondazione Telethon has signed an important agreement to collaborate with the international pharma company Shire plc.
Molecular bullets on the way for cystic fibrosis, Sma and haemophilia
Researchers at the ICGEB in Trieste and at Ferrara University have created a therapeutic strategy based on small RNAs in order to bypass the genetic defect responsible for these serious diseases still without a permanent cure.
Telethon research: link found between inherited mental retardation and sleep cycle regulation
earning and memory deficiencies are correlated to alterations in sleep and wake cycles. This is the outcome of an animal model study conducted on a genetic form of mental retardation and published on Nature Neuroscience* by Maria Passafaro, a researcher of the Istituto Telethon Dulbecco.